Stryker Corporation (SYK): financials, SEC filings and peers

Stryker Corporation (SYK) is a health care equipment company in the Health Care sector of the S&P 500, headquartered in Kalamazoo, Michigan.

It was founded in 1941 and joined the S&P 500 on December 12, 2000.

Its fiscal year ends in December, and its shares trade on the NYSE.

In its SEC filings it is classified as “Surgical & Medical Instruments & Apparatus”.

Stryker Corporation at a glance

Revenue (12 months): $26.3B
Revenue growth: +7.9%
Operating margin: 20.7%
Net income (12 months): $3.6B
Free cash flow (12 months): $4.6B
Cash: $3.3B
Debt: $15.2B
Diluted EPS (12 months): $9.39

Twelve months to September 30, 2026, from the 10-Q filed October 30, 2026.

Latest twelve months

Over the twelve months to September 30, 2026, Stryker Corporation reported revenue of $26.3 billion, about the same as a year earlier (+7.9%).

Its operating margin was 20.7%, up 5.6 percentage points from a year earlier: for every $100 of sales, about $21 was left as operating profit.

Net income was $3.6 billion (13.8% of revenue), 23.1% higher than a year earlier.

Operating cash flow was $5.4 billion and capital spending $873 million, leaving free cash flow of $4.6 billion (17.4% of revenue).

At the end of the period it held $3.3 billion in cash and $15.2 billion in debt, a net debt position of $11.9 billion.

Five-year trend

Revenue went from $14.4 billion in fiscal 2020 to $25.1 billion in fiscal 2025, about 11.8% a year.
Revenue has grown for 5 fiscal years in a row.
Operating margin widened from 15.5% to 19.5% over the same years.
Free cash flow was positive in each of the last 6 fiscal years.

Fiscal year	2021	2022	2023	2024	2025
Revenue	$17.1B	$18.4B	$20.5B	$22.6B	$25.1B
Revenue growth	19.2%	7.8%	11.1%	10.2%	11.2%
Operating margin	15.1%	15.4%	19.0%	16.3%	19.5%
Net income	$2.0B	$2.4B	$3.2B	$3.0B	$3.2B
Free cash flow	$2.7B	$2.0B	$3.1B	$3.5B	$4.3B
Diluted EPS	$5.21	$6.17	$8.25	$7.76	$8.40

Fiscal years as reported in Stryker Corporation’s 10-K filings. Free cash flow is operating cash flow minus capital spending.

Recent SEC filings

8-K filed November 9, 2026 — Executive or director change; Regulation FD disclosure
10-Q filed October 30, 2026 — quarterly report
8-K filed October 29, 2026 — Earnings results
8-K filed October 6, 2026 — Executive or director change; Regulation FD disclosure
10-Q filed July 31, 2026 — quarterly report
8-K filed July 30, 2026 — Earnings results
8-K filed June 26, 2026 — Other event
8-K filed May 20, 2026 — Executive or director change

All Stryker Corporation filings on SEC EDGAR

Companies like Stryker Corporation

Other S&P 500 companies in Health Care Equipment:

More from Health Care

All 60 Health Care companies →

Questions about Stryker Corporation

Is Stryker Corporation's revenue growing?

Yes. Revenue for the twelve months to September 30, 2026 was $26.3 billion, up 7.9% from a year earlier, according to its SEC filings.

Is Stryker Corporation profitable?

Yes. It earned $3.6 billion in net income over the twelve months to September 30, 2026, a net margin of 13.8%.

Does Stryker Corporation have more cash or more debt?

At September 30, 2026 it had $3.3 billion in cash and $15.2 billion in debt, so more debt than cash.

When did Stryker Corporation last file financial results?

Its latest quarterly report (10-Q) was filed with the SEC on October 30, 2026.

Which companies are similar to Stryker Corporation?

In the S&P 500, Stryker Corporation is grouped in Health Care Equipment within the Health Care sector. Abbott Laboratories (ABT), Baxter International (BAX), Becton Dickinson (BDX), Boston Scientific (BSX), Dexcom (DXCM) are in the same group.

Understand the numbers

Source: Stryker Corporation’s filings with the U.S. Securities and Exchange Commission (EDGAR), retrieved November 11, 2026. Figures are as reported by the company and may be restated. This page is for information only and is not financial advice.